What are the indications for ventriculoperitoneal shunting in normal‑pressure hydrocephalus and how successful is it?

VP Shunting in Normal Pressure Hydrocephalus: Indications and Success Rates

VP shunting is effective for treating idiopathic normal pressure hydrocephalus (iNPH), with approximately 83-96% of patients showing improvement at 6 months, though long-term symptom recurrence occurs in about 45-50% of patients by 1-3 years. 1

Indications for VP Shunting in NPH

The classic presentation requiring consideration for VP shunting includes:

• Hakim triad: Gait disturbance, cognitive decline, and urinary incontinence
• Radiological findings: Ventriculomegaly with normal or mildly elevated CSF opening pressure
• MRI features: Reduced callosal angle and disproportionately enlarged subarachnoid space hydrocephalus (DESH) pattern 2

Patient Selection Algorithm

The most critical step is demonstrating objective improvement with temporary CSF diversion before committing to permanent shunting. This can be accomplished through:

1. External lumbar drainage trial (most commonly used) - positive response increases likelihood of shunt success 1
2. Repeated lumbar punctures - improvement predicts shunt responsiveness 1

Standardized testing before and after temporary CSF diversion should include 3:

• Timed "Up & Go" test
• Tinetti Gait and Balance Assessment (mean improvement of 4.27 points predicts success)
• Berg Balance Scale
• Mini Mental Status Exam
• Trail Making Test Part B
• Rey Auditory and Visual Learning Test

Predictors of Shunt Success

Strong predictors that should guide patient selection 1:

• Elevated Ro (resistance to CSF outflow) - Level B evidence for increased chance of response
• Impaired cerebral blood flow reactivity to acetazolamide on SPECT - Level B evidence
• Shorter duration of gait disturbance - significantly predicts better outcomes 4
• Age is NOT a negative predictor - older patients can still benefit 1

Success Rates and Expected Outcomes

Short-Term Results (≤6 months)

• 96% subjective improvement 1
• 83% objective improvement on timed walk test 1
• Gait improves most reliably - 65% of patients show gait improvement 4
• Cognitive and urinary symptoms improve less consistently (approximately 20% each) 4

Long-Term Results (1-3+ years)

The evidence reveals a concerning pattern of symptom recurrence:

• 45.5% report worsening symptoms at 1 year 3
• 34% experience visual deterioration at 1 year, 45% at 3 years (though this is from IIH literature, not NPH) 5
• Gait improvement is best sustained long-term 6
• Cognitive and urinary symptoms tend to decline after initial improvement 6

However, one high-quality study with 10+ year follow-up showed sustained overall improvement in all symptoms compared to baseline 6, suggesting that with proper valve management, long-term benefit is achievable.

Technical Considerations

VP shunt is preferred over LP shunt due to lower revision rates 5. Key technical points:

• Use programmable valves with antigravity or antisiphon devices to reduce low-pressure headaches 5
• Neuronavigation should be used for placement 5
• Median optimal opening pressure: 120 mmH2O for women, 140 mmH2O for men 7
• Priority should be placed on clinical condition over radiological findings when adjusting valve settings 7

Complications and Revision Rates

Serious adverse event risk is 11% 1, including:

• Subdural hematomas/hygromas: 10-12% 4
• Misplaced catheters: 5% 4
• Asymptomatic hemorrhage: 3% 4
• Shunt malfunction requiring revision: 20% of patients 6
• Valve pressure adjustments needed: 40% of patients 6

Critical caveat: 93.3% of revisions result in clinical improvement 6, emphasizing the importance of strict long-term follow-up to detect malfunction early.

Common Pitfalls to Avoid

1. Don't rely solely on imaging - radiological improvement does not correlate with clinical outcomes 7
2. Don't skip temporary CSF diversion testing - it's the best predictor of success
3. Don't dismiss older patients - age alone should not exclude candidacy 1
4. Don't assume permanent benefit - plan for long-term monitoring and potential valve adjustments
5. Consider comorbidities - diabetes mellitus and prior stroke significantly influence outcomes 7

Patients must be counseled that while initial improvement is likely (83-96%), approximately half may experience symptom recurrence requiring valve adjustment or revision within 1-3 years.